Abstract
A Characterization of Bridging Therapies Leading up to Commercial CAR T-Cell Therapy
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have